The stent in the high-bleeding risk patient: antiplatelet monotherapy?

Dual antiplatelet therapy (DAPT) is the recommended treatment after percutaneous coronary intervention (PCI). The introduction into clinical practice of new drug-eluting stents (DESs) with significantly improved safety profiles has made it possible to shorten the DAPT. Randomized studies have establ...

Descripción completa

Detalles Bibliográficos
Autor principal: Capranzano, Piera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
CCC 2022 - State of the Art Cardiology Supplement Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653147/
https://www.ncbi.nlm.nih.gov/pubmed/36380796
http://dx.doi.org/10.1093/eurheartjsupp/suac074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653147/
https://www.ncbi.nlm.nih.gov/pubmed/36380796
http://dx.doi.org/10.1093/eurheartjsupp/suac074

Ejemplares similares